Active Substance: Recombinant human Epidermal Growth Factor (rhEGF) .
Overview
Welcome to Dwaey, specifically on HEBERPROT-P 75mcg page.
This medicine contains an important and useful components, as it consists of
Recombinant human Epidermal Growth Factor (rhEGF)
is available in the market in concentration
Recombinant Somatropin
Monitor thyroid function; benign intracranial hypertension. DM; may require dose reduction in insulin. Pregnancy. Discontinue treatment if there is evidence of tumour growth. Monitoring in patients with scoliosis is recommended due to risk of progression of scoliosis.
Children's growth disorders, growth hormone deficiency,Turner syndrome, chronic renal failure, Prader-Willi syndrome, intrauterine growth retardation, severe idiopathic short stature
Acute critical illness due to heart or abdominal surgery, multiple accidental trauma or respiratory failure; active neoplasms, proliferative or preproliferative diabetic retinopathy; lactation; patients with closed epiphyses. Intracranial lesions. Patients with Prader-Willi syndrome who are severely obese or have severe respiratory impairment.
Hypothyroidism, peripheral oedema; headache; muscle and joint pain; benign intracranial hypertension. Loss of glycaemic control in diabetics.
2
Somatropin is a synthetic human growth hormone of recombinant DNA origin. It stimulates skeletal and soft tissue growth by promoting cell division, amino acid uptake and protein synthesis. It also possesses both insulin-like and diabetogenic effects.
Concomitant corticosteroid therapy may inhibit the effect of somatropin. Gonadotropins, oestrogens, androgens & anabolic agents.
Information not available